Patients are the reason we come to work each day. They inspire us in our mission to create breakthrough therapies that change lives. Developing new medicines and treatment options for humans and animals is a top priority for Boehringer Ingelheim’s employees – and has been for over 135 years.
Every day our scientists are continuing this commitment to innovation by taking the paths scientifically less travelled. We focus on areas of unmet medical need and thus make a major contribution to improving health. We are innovative in order to provide our patients with a better quality of life and to ensure progressive, preventive animal health.
Our goal is to make sure that we stay at the forefront of science and technology. To achieve our vision, we embrace the power of partnerships and alliances. We supplement our in-house expertise by cooperating with academic institutions and other companies with which we jointly develop scientific innovations.
Within the life science community, we are currently pursuing more than 150 partnerships which represent around 50 percent of our pipeline projects. We share our knowledge and experience and provide promising startups with advice and support in order to accelerate the process from the germination of an idea to the realization of a therapeutic option. We are convinced that by working together we can learn more, do more, and achieve more.
Our commitment to partnerships applies both within our company and outwardly. We are team workers and innovators, and we encourage a diverse, collaborative, and open environment. We work with passion and integrity while aiming for success. We approach one another with respect, trust, and empathy and share a joint vision: to improve human and animal health.